CEO — Aesthetic Neurotoxin Biotech (Equity Opportunity)

Page Executive; United Kingdom; On-site; Confidential; Full time

Job summary

A leading biotech firm in the United Kingdom is seeking an experienced Chief Executive Officer (CEO) to lead their innovative neurotoxin platform. The successful candidate will have a strong background in aesthetic injectables with proven venture fundraising skills and the capability to drive strategic initiatives and partnerships. This role offers a competitive salary of $400,000 to $500,000 USD, along with comprehensive benefits and the opportunity to shape a dynamic organization in the biopharmaceutical industry.

Benefits

Competitive annual salary

Short term and long term incentives

Comprehensive local benefits package

Collaborative work environment

Qualifications

• Proven CEO or serial entrepreneur with direct experience in aesthetic neurotoxins or injectable aesthetics.
• Demonstrated success in taking products from early development through launch.
• Strong track record in venture fundraising and strategic deal-making.

Responsibilities

• Define and execute the company's overall strategy.
• Lead equity financing activities and manage investor relations.
• Drive strategic partnerships and collaboration opportunities.
• Oversee R&D, regulatory, clinical, and commercial readiness.
• Interface with the Board ensuring transparent communication.

Skills

Venture fundraising

Strategic deal-making

Leadership in R&D and regulatory

Team building

Hands-on operation in biotech

Job description

A leading biotech firm in the United Kingdom is seeking an experienced Chief Executive Officer (CEO) to lead their innovative neurotoxin platform. The successful candidate will have a strong background in aesthetic injectables with proven venture fundraising skills and the capability to drive strategic initiatives and partnerships. This role offers a competitive salary of $400,000 to $500,000 USD, along with comprehensive benefits and the opportunity to shape a dynamic organization in the biopharmaceutical industry.